Hepatitis in AIDS patients

Area of Science:

• Infectious Diseases
• Hepatology
• Virology

Background:

• Individuals with human immunodeficiency virus (HIV) exhibit increased susceptibility to coinfections with hepatitis C virus (HCV) and hepatitis B virus (HBV).
• Common transmission routes for HIV, HCV, and HBV include sexual contact, injection drug use, and perinatal exposure.
• Liver disease is a primary cause of morbidity and mortality in HIV-infected individuals, a condition exacerbated by HCV and HBV coinfections, even with antiretroviral therapy.

Purpose of the Study:

• To review the epidemiology and clinical implications of HBV and HCV coinfections in patients with HIV.
• To summarize current therapeutic approaches for managing HBV and HCV in the context of HIV infection.

Main Methods:

• This is a review article, synthesizing existing literature on HIV, HBV, and HCV coinfections.
• Information was gathered on transmission, pathogenesis, clinical impact, and treatment strategies.

Main Results:

• HBV and HCV coinfections significantly increase the risk of liver-related complications and mortality in HIV-positive individuals.
• Effective management of HBV involves nucleos(t)ide analogues.
• HCV treatment typically involves Pegylated Interferon (PegIFN) and ribavirin, or protease inhibitors.

Conclusions:

• Coinfection with HBV and/or HCV presents a substantial challenge in managing HIV patients, impacting liver health and overall prognosis.
• Antiviral therapies are crucial for managing these coinfections, improving outcomes for coinfected individuals.
• Further research and integrated treatment strategies are needed for optimal patient care.